Table 1 Parameters used in the model^a

	Point estimate		Source
	Men	Women
Utilities, mean (s.e.)			Estimated based on Saarni et al. (2006) and Soini et al. (2010)
30–44	0.917 (0.003)	0.906 (0.003)
45–54	0.876 (0.005)	0.865 (0.005)
55–64	0.821 (0.006)	0.810 (0.006)
65–74	0.781 (0.008)	0.770 (0.008)
Disutility due to CVD event, mean (s.e.)
Stroke	−0.145 (0.097)		Lindgren et al. (2007)
AMI	−0.092 (0.029)		Soini et al. (2010)
Post stroke	−0.090 (0.020)		Saarni et al. (2006)
Post MI	−0.011 (0.009)		Saarni et al. (2006)
Costs, mean (s.e.)
Stroke, mean (s.e.)^b	23 240€		Meretoja et al. (2010)
AMI
30–44	16 245€ (762)	16 215€ (760)	Häkkinen et al. (2007)
45–54	14 955€ (701)	17 503€ (820)
55–64	14 446€ (677)	16 326€ (765)
65–74	12 995€ (609)	14 958€ (701)
Fatal AMI^c	2294€		Hujanen et al. (2008)
Rehabilitation after stroke (first year)	6182€		Assumption based on information from SII's database
Rehabilitation after MI (first year)	2576€		Assumption based on information from SII's database
Antihypertensive medication in the primary prevention per year	314	302
Dyslipidaemia therapy in the primary prevention per year	195	166
Monitoring a patient receiving antihypertensive medication	224€		Assumption based on SII data
Monitoring a patient receiving statins	185€		Assumption based on SII data
Monitoring a patient in secondary prevention	388€		Assumption based on SII data
Productivity loses due to non-fatal stroke	11 700€		Vohlonen et al. (2002)
Productivity loses due to non-fatal MI	6884€		Vehviläinen et al. (2004)

Abbreviations: AMI, acute myocardial infarction; CVD, cardiovascular disease; MI, myocardial infarction; SII, Social Insurance Institution of Finland (Kela).
Costs are presented in year 2009 values.
^bEstimate is a weighted average cost of treatment of ischemic stroke (79.4%), subarachnoid haemorrhage (13.6%) and intracerebral haemorrhage (7%).
^cA patient died during a hospitalisation.

Search